Deutsche Bank Ag\ Vir Biotechnology, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 189,219 shares of VIR stock, worth $1.44 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

189,219

Previous 46,037 311.02%

Holding current value

$1.44 Million

Previous $409,000 246.45%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$7.26 - $10.7 $1.04 Million - $1.53 Million	143,182 Added 311.02%	189,219 $1.42 Million
Q2 2024 Aug 14, 2024	BUY	$7.63 - $12.66 $34,884 - $57,881	4,572 Added 11.03%	46,037 $409,000
Q1 2024 May 15, 2024	BUY	$8.6 - $11.9 $34 - $47	4 Added 0.01%	41,465 $420,000
Q4 2023 Feb 14, 2024	SELL	$7.76 - $10.29 $7,876 - $10,444	-1,015 Reduced 2.39%	41,461 $417,000
Q3 2023 Nov 09, 2023	BUY	$9.14 - $24.62 $47,701 - $128,491	5,219 Added 14.01%	42,476 $398,000
Q2 2023 Aug 14, 2023	SELL	$23.2 - $27.29 $1.79 Million - $2.1 Million	-76,950 Reduced 67.38%	37,257 $913,000
Q1 2023 May 15, 2023	SELL	$22.26 - $30.85 $642,868 - $890,948	-28,880 Reduced 20.18%	114,207 $2.66 Million
Q4 2022 Feb 13, 2023	BUY	$19.96 - $28.22 $2.07 Million - $2.93 Million	103,692 Added 263.21%	143,087 $3.62 Million
Q3 2022 Nov 14, 2022	SELL	$18.26 - $31.1 $70,209 - $119,579	-3,845 Reduced 8.89%	39,395 $759,000
Q2 2022 Aug 11, 2022	SELL	$19.08 - $26.7 $23,621 - $33,054	-1,238 Reduced 2.78%	43,240 $1.1 Million
Q1 2022 May 13, 2022	SELL	$21.19 - $40.01 $79,420 - $149,957	-3,748 Reduced 7.77%	44,478 $1.14 Million
Q4 2021 Feb 11, 2022	SELL	$30.97 - $54.03 $51,905 - $90,554	-1,676 Reduced 3.36%	48,226 $2.02 Million
Q3 2021 Nov 04, 2021	BUY	$34.9 - $54.54 $96,393 - $150,639	2,762 Added 5.86%	49,902 $2.17 Million
Q2 2021 Aug 11, 2021	BUY	$38.75 - $51.0 $205,762 - $270,810	5,310 Added 12.69%	47,140 $2.23 Million
Q1 2021 May 13, 2021	SELL	$26.34 - $83.07 $102,673 - $323,806	-3,898 Reduced 8.52%	41,830 $2.14 Million
Q4 2020 Feb 16, 2021	BUY	$25.51 - $43.38 $380,736 - $647,446	14,925 Added 48.45%	45,728 $1.23 Million
Q3 2020 Nov 12, 2020	BUY	$28.28 - $53.6 $209,554 - $397,176	7,410 Added 31.68%	30,803 $1.06 Million
Q2 2020 Aug 13, 2020	BUY	$27.89 - $47.86 $582,956 - $1 Million	20,902 Added 839.1%	23,393 $958,000
Q1 2020 May 14, 2020	SELL	$12.04 - $60.2 $3,852 - $19,264	-320 Reduced 11.38%	2,491 $86,000
Q4 2019 Feb 14, 2020	BUY	$11.83 - $15.85 $33,254 - $44,554	2,811 New	2,811 $34,000

Others Institutions Holding VIR

# of Institutions

219

Shares Held

87.4M

Call Options Held

127K

Put Options Held

1.19M

View Full List

About Vir Biotechnology, Inc.

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $1.01B
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

More about VIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account